CARDLYTICS, INC. (CDLX) Free cash flow 2016–2025
CARDLYTICS, INC. (CDLX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$8.8MFY2025 · since FY2016: -$34.3M → $8.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.8M | +184.8% |
| FY2024 | -$10.4M | -1119.0% |
| FY2023 | -$852,000 | +98.5% |
| FY2022 | -$55.1M | -32.3% |
| FY2021 | -$41.6M | -220.1% |
| FY2020 | -$13.0M | -509.0% |
| FY2019 | $3.2M | +112.8% |
| FY2018 | -$24.9M | -6.9% |
| FY2017 | -$23.3M | +32.1% |
| FY2016 | -$34.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CDLX financial trends
CDLX RevenueCDLX Net incomeCDLX Net marginCDLX Gross profitCDLX Gross marginCDLX Operating incomeCDLX Operating marginCDLX Operating cash flowCDLX Capital expendituresCDLX Return on equityCDLX Stock buybacksCDLX Dividends paidCDLX Total assetsCDLX Total liabilitiesCDLX Shareholders’ equityCDLX overview →